With the raised guidance throughout the year, it feels like we have released the handbrake and are moving at very high pace in terms of growth rates, said CFO Karsten Munk Knudsen in a call with analysts
This makes retatrutide one of the first therapies to show real potential in addressing this fast-growing condition, which is often linked to obesity and diabetes
How to Navigate Patient Questions About OffLabel GLP1 Use First, begin with active listening
Residual Solvent Testing Residual solvent testing evaluates solvents that may remain from synthesis, purification, or processing
American Diabetes Associations 77th Scientific Session 2017
Ozempic was approved for type 2-diabetes in 2017, but it became increasingly common for doctors to prescribe it to obese patients off-label as a treatment to control weight